In a study published August 13, 2020, in Cell by a team of collaborators from Memorial Sloan Kettering and Weill Cornell Medicine, researchers report that tiny packages of materials released by tumors, called EVPs (extracellular vesicles and particles), may serve as biomarkers for detecting a number of different types of cancer in the early stages.
- Football-loving states slow to enact youth concussion laws
- Lab results don’t explain ‘obesity paradox,’ but bias may
- New device offers faster way to detect antibiotic-resistant bacteria
- Flashy lizards are more attractive to mates and to predators
- Octapharma USA presents bleeding disorders research at virtual ASH annual meeting